Robot‐assisted radical prostatectomy using hugo RAS system: The pioneer experience in Taiwan and Northeast Asia
Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Min‐Che Tung(National Chung Hsing University), Yung‐Shun Juan(Kaohsiung Medical University Chung-Ho Memorial Hospital), Hsien‐Che Ou(Kaohsiung Medical University), Che‐Hsueh Yang(Changhua Christian Hospital), Li Huang(Tungs' Taichung MetroHarbor Hospital), Wei‐Chun Weng(Mackay Junior College of Medicine, Nursing and Management), Chao‐Yu Hsu(National Chung Hsing University), Alexandre Mottrie(Instituut voor Landbouw en Visserijonderzoek), Ragavan Narasimhan(Apollo Hospitals), Yi‐Sheng Lin(Peking University)
International Journal of Medical Robotics and Computer Assisted Surgery
September 13, 2023
Cited by 20
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy
|British Journal of Urology|2010|141